KIAA2013

Across TCGA pan-cancer cohorts, KIAA2013 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated KIAA2013 data layer compared with 25 for mass-spec protein and 4 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher KIAA2013 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated KIAA2013 expression acts as an unfavorable survival marker, although some lineages such as HNSC and UCEC show a favorable association.

HNSC, CCRCC, and UCEC are the cancer types where KIAA2013 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Tertile	All	0.954	0.698	<.001	45	view →
CCRCC	DFS	Median	III,IV	0.514	0.796	.016	9	view →
UCEC	OS	Tertile	II,III,IV	1.000	0.654	.046	4	view →
LUAD	OS	Median	III,IV	0.787	0.260	.007	3	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

KIAA2013–HNSC (DFS)

Open the HNSC breakdown →